Insulin aspart, recombinant Subcutaneous and Leader Heartburn Relief
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Leader Heartburn Relief and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: cimetidine
Brand name: Tagamet HB, Tagamet
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Leader Nicotine Polacrilex gum, lozenge
- Insulin aspart, recombinant Subcutaneous-Leader Sleep Aid
- Insulin aspart, recombinant Subcutaneous-Ledipasvir and sofosbuvir
- Insulin aspart, recombinant Subcutaneous-Ledipasvir and Sofosbuvir Tablets
- Insulin aspart, recombinant Subcutaneous-Leena
- Insulin aspart, recombinant Subcutaneous-Lefamulin
- Leader Heartburn Relief-Insulin degludec
- Leader Heartburn Relief-Insulin Degludec (U-100) Prefilled Pens
- Leader Heartburn Relief-Insulin Degludec (U-100) Vials
- Leader Heartburn Relief-Insulin Degludec (U-200) Prefilled Pens
- Leader Heartburn Relief-Insulin degludec and liraglutide
- Leader Heartburn Relief-Insulin degludec and liraglutide Subcutaneous